Without A Prescription |
| ||
|
Famox Pepcid |
|
| ||
Home » Prescription Drugs 7 » Famox Pepcid Indications:1.Duodenal ulcer 2.Benign gastric ulcer 3.Hypersecretory conditions such as Zollinger-Ellison syndrome 4.Prevention of relapses of duodenal ulceration 5.Prevention of relapses of benign gastric ulcer 6.Symptomatic relief of gastroesophageal reflux disease. 7.Healing of oesophageal erosion or ulceration associated with gastroesophageal reflux disease 8.Prevention of relapses of symptoms and erosions or ulcerations associated with GERD. Dosage and AdministrationDuodenal Ulcer:Initial Therapy: The recommended dose of famotidine is one 40mg tablet daily taken at night. Treatment should be given for four to eight weeks but the duration of treatment may be shortened if endoscopy reveals that the ulcer has healed. In most cases of duodenal ulcer healing occurs within four weeks on this regimen. In those patients whose ulcers have not healed completely after four weeks treatment should be continued for a further four week period.Maintenance Therapy: For the prevention of recurrence of duodenal ulceration it is recommended that therapy with famotidine be continued with a dose of one 20mg tablet daily taken at night.Benign Gastric Ulcer:The recommended dose of famotidine is one 40mg tablet daily taken at night. Treatment should be given for 4-8 weeks but the duration of treatment may be shortened if endoscopy reveals that the ulcer has healed.Maintenance Therapy: For the prevention of recurrence of benign gastric ulcer the recommended dosage is one 20mg tablet taken at night which may be given for up to one year.Zollinger-Ellison Syndrome:Patients without prior antisecretory therapy should be started on a dose of 20mg every 6 hours. Dosage should be adjusted to individual patient needs and should continue for as long as indicated clinically. Doses up to 800mg daily have been used for up to one year without the development of significant adverse effects or tachyphylaxis. Patients who have been receiving another H2-antagonist may be switched directly to famotidine at a starting dose higher than that recommended for new cases; this starting dose will depend on the severity of the condition and the last dose of the H2-antagonist previously used.Gastroesophageal Reflux Disease:The recommended dosage for the symptomatic relief of gastroesophageal reflux disease is 20mg of famotidine twice daily.For the treatment of oesophageal erosion or ulceration associated with GERD the recommended dosage is 40mg of famotidine twice daily.Maintenance Therapy: For the prevention of recurrence of symptoms and erosions or ulcerations associated with GERD the recommended dosage is 20mg of famotidine twice daily.Dosage Adjustment for Patients with Severe Renal Insufficiency:In adult patients with moderate (creatinine clearance <50mL/min) or severe (creatinine clearance <10mL/min) renal insufficiency the elimination half-life of famotidine is increased. For patients with severe renal insufficiency it may exceed 20 hours reaching approximately 24 hours in anuric patients. Since CNS adverse effects have been reported in patients with moderate and severe renal insufficiency to avoid excess accumulation of the medicine in patients with moderate and severe renal insufficiency the dose of famotidine may be reduced to half the dose or the dosing interval may be prolonged to 36-48 hours as indicated by the patient's clinical response Buy Famox Pepcid and other Prescription Drugs 7 products online at Medstore. Buy Online at Medstore - Click Here!
About Famox Pepcid: Product Type: Prescription Drugs 7 Famox ( Pepcid Generic Famotidine ) Famox (Pepcid Generic Famotidine) Pepcid Generic Famotidine 20mg 40mg 250 Tablets 500(2 x 250) Tablets Pepcid Generic Famotidine Famox
View more Prescription Drugs 7 Without A Prescription: Education on antibiotic prescribing in Quebec worked. Guidelines for Quebec doctors on proper antibiotic use led to a decline in these prescriptions in the province, while prescribing rose in other provinces, a new study suggests. The guidelines were published and disseminated to Quebec doctors and pharmacists in January 2005 due to worries about the overuse of antibiotics and partly as a response to an outbreak of Clostridium difficile infections. Antibiotic consumption per capita was already 23.3 per cent higher in Canada generally than in Quebec in 2004, the study showed. But in the year that followed publication of the guidelines, the number of outpatient antibiotic prescriptions in Quebec decreased 4.2 per cent, the study said, while increasing 6.5 per cent in other Canadian provinces. The trend persisted three years later.
| ||
